Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : NOVN    save search

Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI™
Published: 2024-04-03 (Crawled : 14:30) - biospace.com/
LGND | $72.59 0.1% 0.1% 140K twitter stocktwits trandingview |
Health Technology
| | O: -0.83% H: 3.14% C: 2.93%

pharmaceuticals commercialization therapeutics
Delisting of Securities of Nymox Pharmaceutical Corporation; Aridis Pharmaceuticals Inc.; Novan, Inc.; ViewRay, Inc.; 9 Meters Biopharma, Inc.; Nabriva Therapeutics plc; UTA Acquisition Corporation; AppHarvest, Inc.; Yellow Corporation; Proterra Inc.; Amyris, Inc.; Chain Bridge I; LatAmGrowth SPAC; and SpringBig Holdings, Inc. from The Nasdaq Stock Market
Published: 2023-09-07 (Crawled : 20:00) - globenewswire.com
AMRSQ | $0.0015 -95.0% 21K twitter stocktwits trandingview |
Manufacturing
| | O: -10.0% H: 16.05% C: 8.64%
VRAYQ | $0.0001 0.0% 600 twitter stocktwits trandingview |
Manufacturing
| | O: 6.84% H: 13.6% C: -4.0%
NDAQ | $60.35 0.47% 0.46% 3.1M twitter stocktwits trandingview |
Finance
| | O: 0.0% H: 0.19% C: -0.45%
ARDS | $0.0615 2.82% 410K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 13.45% C: -12.07%

nasdaq acquisition pharmaceuticals therapeutics proterra market
Ligand Offers $15 Million to Acquire Assets of Novan, Inc.
Published: 2023-07-17 (Crawled : 14:20) - biospace.com/
NOVN | $0.0941 -24.84% -32.91% 7.2M twitter stocktwits trandingview |
Health Technology
| | O: -63.13% H: 2.09% C: -20.11%
LGND | $72.59 0.1% 0.1% 140K twitter stocktwits trandingview |
Health Technology
| | O: 0.94% H: 1.74% C: 0.39%

acquire
Novan Enters into Agreement to Sell Substantially All of its Assets, including Berdazimer Gel, 10.3% (SB206), and Files for Chapter 11 Protection
Published: 2023-07-17 (Crawled : 13:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M twitter stocktwits trandingview |
Health Technology
| | O: -63.13% H: 2.09% C: -20.11%
LGND | $72.59 0.1% 0.1% 140K twitter stocktwits trandingview |
Health Technology
| | O: 0.94% H: 1.74% C: 0.39%

sb206 agreement
Novan to Provide Corporate Update at its 2023 Annual Meeting of Stockholders
Published: 2023-06-05 (Crawled : 13:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M twitter stocktwits trandingview |
Health Technology
| | O: 2.65% H: 4.31% C: -0.86%

update meeting
Novan Focuses Strategic Direction and Announces Restructuring
Published: 2023-05-31 (Crawled : 20:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M twitter stocktwits trandingview |
Health Technology
| | O: -8.82% H: 0.0% C: -9.68%


Novan Reports First Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-05-15 (Crawled : 11:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M twitter stocktwits trandingview |
Health Technology
| | O: -6.25% H: 1.58% C: -3.33%

update financial results
Novan to Report First Quarter 2023 Financial Results on May 15, 2023
Published: 2023-05-08 (Crawled : 13:20) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.88% H: 4.42% C: -1.77%

report financial results
Novan Announces Publication of Psoriasis Patient Data Demonstrating Need for Rapid Symptom Improvement¹
Published: 2023-04-27 (Crawled : 13:20) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M twitter stocktwits trandingview |
Health Technology
| | O: -1.61% H: 4.1% C: 0.82%

rapid psoriasis publication
Novan to Host Analyst and Investor Event: A Discussion of Molluscum’s Unmet Need with Pediatric Dermatologist Jeffrey Sugarman, MD, PhD
Published: 2023-04-20 (Crawled : 13:20) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M twitter stocktwits trandingview |
Health Technology
| | O: -2.24% H: 3.05% C: 1.53%


Novan Reports Full Year 2022 Financial Results and Provides Corporate Update
Published: 2023-03-30 (Crawled : 11:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M twitter stocktwits trandingview |
Health Technology
| | O: 7.21% H: 7.55% C: 0.84%

year update financial results
Novan to Report Full Year 2022 Financial Results on March 30, 2023
Published: 2023-03-23 (Crawled : 13:00) - novan.com
NOVN | $0.0941 -24.84% -32.91% 7.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.81% H: 0.0% C: -8.0%

report year financial results
Novan Announces Closing of $6.0 Million Registered Direct Offering
Published: 2023-03-16 (Crawled : 21:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.88% C: -5.31%

direct offering
Novan to Present at the Oppenheimer 33rd Annual Healthcare ConferencePresentation with live webcast today, March 14th at 10:40 AM ET
Published: 2023-03-14 (Crawled : 14:00) - biospace.com/
NOVN | $0.0941 -24.84% -32.91% 7.2M twitter stocktwits trandingview |
Health Technology
| | O: -5.88% H: 8.04% C: 4.46%


Novan to Present at the Oppenheimer 33rd Annual Healthcare Conference
Published: 2023-03-14 (Crawled : 12:20) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M twitter stocktwits trandingview |
Health Technology
| | O: -5.88% H: 8.04% C: 4.46%

conference
Novan Announces $6.0 Million Registered Direct Offering
Published: 2023-03-14 (Crawled : 12:20) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M twitter stocktwits trandingview |
Health Technology
| | O: -5.88% H: 8.04% C: 4.46%

offering direct
Novan Moves Forward with Unified Corporate Branding
Published: 2023-03-08 (Crawled : 14:00) - novan.com
NOVN | $0.0941 -24.84% -32.91% 7.2M twitter stocktwits trandingview |
Health Technology
| | O: 4.44% H: 0.0% C: -4.26%


FDA Accepts Novan’s NDA for Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum with a PDUFA Goal Date of January 5, 2024
Published: 2023-03-08 (Crawled : 03:00) - novan.com
NOVN | $0.0941 -24.84% -32.91% 7.2M twitter stocktwits trandingview |
Health Technology
| | O: 4.44% H: 0.0% C: -4.26%

molluscum treatment fda pdufa
FDA Accepts Novan’s NDA for Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum with a PDUFA Goal Date of January 5, 2024
Published: 2023-03-07 (Crawled : 13:20) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M twitter stocktwits trandingview |
Health Technology
| | O: 5.3% H: 1.44% C: -2.88%

molluscum treatment fda pdufa
Novan to Present at the Virtual Investor 2023 Companies to Watch Event
Published: 2023-01-18 (Crawled : 13:20) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.77% H: 5.14% C: -2.29%

companies
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.